Could a stomach shield drug replace acid blockers for steroid users?
NCT ID NCT07654049
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether teprenone, a stomach-protecting drug, can reduce gastrointestinal damage caused by high-dose steroids in people with lupus. One hundred participants will be randomly assigned to take either teprenone or the standard acid-blocker omeprazole for 12 weeks. The goal is to see if teprenone works as well or better at easing stomach symptoms and preventing injury.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Teprenone
- What this could lead to
- If it works, this could offer a gentler alternative to standard acid-blockers for preventing stomach damage from steroids.
- What could go wrong
- This is a small, early-stage trial with only 100 participants, so results may not apply to everyone. Teprenone may not be as effective as omeprazole.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL AND DIGESTIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?